Trial intelligence / Profile preview

Lornoxicam Infusion vs Scheduled Dosing for Post-Op Pain

NCT01718756Phase 2Suspended

Sponsor
Mansoura University
Start
Jun 2013
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lornoxicam in postoperative pain, sponsored by Mansoura University. Started Jun 2013; status: suspended.

02

Drugs

lornoxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01718756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01718756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call